Kimberly is a registered patent agent in Canada and the United States. With a PhD in chemistry, Kimberly provides specialized expertise to clients ranging from academic/research institutes and startups to pharmaceutical small and medium-sized enterprises (SMEs) and larger blue chip companies. She thrives on the challenge of figuring out how best to claim, strengthen and protect her clients’ inventions in order to create a strategic patent portfolio. Her expertise and prominence in the field has earned her recognition as one of the leading Canadian patent practitioners in IAM Patent 1000.
Kimberly has extensive experience in drafting and prosecuting patent and design applications, preparing patentability, infringement, validity and freedom-to-operate opinions, providing worldwide strategic patent and design portfolio management and conducting due diligence in patent and design valuations.
Kimberly’s practice focuses on the areas of chemistry, pharmaceutics, medical devices, aerospace and aeronautics, energy and mining. More specifically, she specializes in the fields of organic and inorganic chemistry, such as pharmaceutical formulations, polymers, surfactants, petroleum, propellants, electrochemistry, photochemistry and synthesis. Kimberly’s post-doctoral research experience in chemistry related to synthesis of new drugs for photodynamic therapeutic treatment of cancer (Queen Mary and Westfield College, London, England) and the development of new polymeric materials and methodologies for holographic data storage (NSF Center for Photoinduced Charge Transfer, University of Rochester, Rochester, NY). During that time she co-authored several well-known scientific publications.
Kimberly serves on the Canadian Patent Agent Examining Board for the qualification of Canadian Patent Agents as well as the Intellectual Property Owners Association Canadian Practice Committee. She is also a Fellow of the Intellectual Property Institute of Canada (IPIC) and a member of the Association of University Technology Managers (AUTM).